Capital DailyCapital Daily
Finance

Community Healthcare Trust vs. Sabra Health Care REIT: Which Real Estate Stock Is a Better Buy in 2026?

One REIT boasts nearly 200 outpatient sites, while the other manages over 36,000 senior care beds. Explore how their financials and risk profiles stack up.

Community Healthcare Trust vs. Sabra Health Care REIT: Which Real Estate Stock Is a Better Buy in 2026?

Community Healthcare Trust vs. Sabra Health Care REIT: Which Real Estate Stock Is a Better Buy in 2026?

Published June 15, 2026 · Category: Finance

Overview

Investors seeking reliable income often look to healthcare properties for stability, which makes the choice between Community Healthcare Trust (NYSE:CHCT) and Sabra Health Care REIT (NASDAQ:SBRA) a compelling comparison for 2026.

Community Healthcare Trust carves out a niche by focusing on smaller outpatient facilities, whereas Sabra Health Care REIT operates as an industry giant with a wide reaching portfolio of long-term care beds. Both companies offer unique advantages depending on your preference for specialized niche properties or broad scale within the medical facility landscape.

Details

Community Healthcare Trust targets a specific niche within the healthcare sector by acquiring outpatient facilities in non-urban and suburban markets. The portfolio consists of nearly 198 properties across 35 states, serving a variety of medical providers such as behavioral health and specialty clinics. While the company maintains a broad tenant base, its largest rent contributors include US HealthVest at roughly 7.3% and Lifepoint Health at approximately 6.4% of annualized rent.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.